ADDING HYDROCHLOROTHIAZIDE PROVIDES DOSE-DEPENDENT SEATED BLOOD PRESSURE REDUCTIONS IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSION NOT CONTROLLED BY OLMESARTAN MEDOXOMIL 40MG

被引：0

作者：

Rump, L. ^{[1
]}

Sellin, L. ^{[1
]}

Ammentorp, B. ^{[2
]}

Schmitt, J. ^{[2
]}

Laeis, P. ^{[2
]}

机构：

[1] Univ Klinikum Duesseldorf, Klin Nephrol, Dusseldorf, Germany

[2] Daiichi Sankyo Europe GmbH, Munich, Germany

来源：

JOURNAL OF HYPERTENSION | 2010年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：E109 / E110

页数：3

共 29 条

[1] ADDING HYDROCHLOROTHIAZIDE (HCTZ) PROVIDES DOSE-DEPENDENT AMBULATORY BLOOD PRESSURE (ABP) REDUCTIONS IN MODERATE-TO-SEVERE PATIENTS UNCONTROLLED BY OLMESARTAN MEDOXOMIL (OM) 40MG
Rump, L.
Sellin, L.
Ammentorp, B.
Schmitt, J.
Laeis, P.
JOURNAL OF HYPERTENSION, 2010, 28 : E114 - E115
[2] Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension
Fogari, Roberto
Taddei, Stefano
Holm-Bentzen, Merete
Baszak, Jacek
Melani, Lorenzo
Schumacher, Kai
CLINICAL DRUG INVESTIGATION, 2010, 30 (09) : 581 - 597
[3] HYDROCHLOROTHIAZIDE (HCTZ) PROVIDES ADDITIONAL BLOOD PRESSURE (BP)-LOWERING WHEN USED AS AN ADD-ON THERAPY IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSION WHOSE BP IS NOT ADEQUATELY CONTROLLED BY OLMESARTAN MEDOXOMIL (OM) 40 MG MONOTHERAPY
Rump, L. C.
Girerd, X.
JOURNAL OF HYPERTENSION, 2009, 27 : S282 - S282
[4] Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension
Rosenbaum, David
Girerd, Xavier
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (02) : 179 - 186
[5] Olmesartan/hydrochlorothiazide provides consistent, dose-dependent blood pressure lowering over the full 24-h dosing period in grade 2/3 hypertensive patients uncontrolled by olmesartan 40mg
Rump, L. C.
Girerd, X.
Sellin, L.
Stegbauer, J.
Laeis, P.
Ammentorp, B.
Schmitt, J.
EUROPEAN HEART JOURNAL, 2010, 31 : 532 - 533
[6] Additional, dose-dependent ambulatory blood pressure threshold achievement is achieved by adding hydrochlorothiazide in grade 2/3 hypertensive patients uncontrolled by OM 40mg
Rump, L. C.
Girerd, X.
Sellin, L.
Stegbauer, J.
Laeis, P.
Ammentorp, B.
Schmitt, J.
EUROPEAN HEART JOURNAL, 2010, 31 : 692 - 692
[7] OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE (OM/HCTZ) 40/25MG PROVIDES GREATER AMBULATORY BLOOD PRESSURE-LOWERING VS OM/HCTZ 20/25MG IN MODERATE-TO-SEVERE PATIENTS UNCONTROLLED BY OM
Rump, L.
Pothoff, S.
Ammentorp, B.
Schmitt, J.
Laeis, P.
JOURNAL OF HYPERTENSION, 2010, 28 : E110 - E110
[8] BLOOD PRESSURE (BP) THRESHOLD ATTAINMENT WITH OLMESARTAN MEDOXOMIL/AMLODIPINE (OLM/AML) IN PATIENTS WITH MODERATE TO SEVERE HYPERTENSION
Burnier, M.
Mourad, J-J.
Koch, W.
JOURNAL OF HYPERTENSION, 2009, 27 : S281 - S282
[9] Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension
L C Rump
X Girerd
L Sellin
J Stegbauer
Journal of Human Hypertension, 2011, 25 : 565 - 574
[10] Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension
Rump, L. C.
Girerd, X.
Sellin, L.
Stegbauer, J.
JOURNAL OF HUMAN HYPERTENSION, 2011, 25 (09) : 565 - 574

← 1 2 3 →